
Tempus to Present Six Abstracts at ESMO Congress 2025
Tempus AI, Inc., a technology company leading the adoption of AI to advance precision medicine, announced that six abstracts have been accepted for presentation at
Tempus AI, Inc., a technology company leading the adoption of AI to advance precision medicine, announced that six abstracts have been accepted for presentation at